(D-Ala7)-Angiotensin I/II (1-7)

(D-Ala7)-Angiotensin I/II (1-7) is a synthetic peptide analog derived from the naturally occurring angiotensin peptides, designed to incorporate a D-alanine substitution at the seventh amino acid position. This molecular modification enhances the peptide's stability against enzymatic degradation, thereby extending its biological half-life and functional activity in various experimental settings. As a research tool, (D-Ala7)-Angiotensin I/II (1-7) offers a unique profile that allows scientists to dissect the physiological and pharmacological roles of the angiotensin (1-7) axis within the broader renin-angiotensin system. Its distinct structure provides a valuable means to differentiate the effects of endogenous angiotensin peptides from those of their analogs, facilitating a deeper understanding of peptide-receptor interactions and downstream signaling pathways. Due to its enhanced resistance to peptidases, this analog is particularly well-suited for in vitro and in vivo studies that require prolonged peptide activity, making it an indispensable reagent in cardiovascular, renal, and metabolic research.

Cardiovascular research: (D-Ala7)-Angiotensin I/II (1-7) is widely utilized in cardiovascular studies to elucidate the mechanisms underlying blood pressure regulation and vascular function. By acting as a selective agonist or antagonist of the Mas receptor, it enables researchers to investigate the counter-regulatory effects of the angiotensin (1-7) pathway relative to the classical angiotensin II axis. This analog is instrumental in experiments exploring endothelial function, vascular remodeling, and the balance between vasodilatory and vasoconstrictive forces within the circulatory system. Its application has contributed to the identification of novel therapeutic targets and pathways involved in maintaining cardiovascular homeostasis.

Renal physiology: In the context of renal research, (D-Ala7)-Angiotensin (1-7) serves as a critical probe for studying the protective actions of the non-classical renin-angiotensin system on kidney function. Researchers employ this peptide to assess its influence on glomerular filtration, tubular reabsorption, and renal hemodynamics. The analog's resistance to enzymatic breakdown allows for more consistent and reproducible results in both acute and chronic experimental models. Its use has shed light on the mechanisms by which the angiotensin (1-7) axis mitigates fibrotic processes and modulates sodium and water balance, thereby advancing the understanding of renal pathophysiology.

Metabolic studies: Scientists investigating metabolic disorders leverage (D-Ala7)-Angiotensin I/II (1-7) to explore its impact on glucose homeostasis, lipid metabolism, and insulin sensitivity. By modulating the activity of the Mas receptor, this peptide analog provides a means to delineate the metabolic benefits associated with the angiotensin (1-7) pathway. Experimental data suggest that it plays a role in improving glucose uptake, reducing inflammation, and enhancing lipid profiles in various model systems. Its application is pivotal for unraveling the crosstalk between the renin-angiotensin system and metabolic regulation, offering new perspectives for research into diabetes and obesity.

Neuroscience research: The utility of (D-Ala7)-Angiotensin I/II (1-7) extends to neuroscience, where it is employed to investigate the peptide's neuromodulatory effects within the central nervous system. Through its interactions with the Mas receptor, the analog has been shown to influence neurotransmitter release, synaptic plasticity, and neuroinflammatory processes. Researchers use it to dissect the neuroprotective properties of the angiotensin (1-7) axis in models of cognitive impairment, neurodegeneration, and brain injury. Its stable profile ensures reliable experimental outcomes, making it a valuable asset in the study of brain function and disease mechanisms.

Vascular biology: In vascular biology, (D-Ala7)-Angiotensin I/II (1-7) is an essential tool for probing the molecular and cellular processes that govern vascular tone, permeability, and remodeling. By selectively activating or inhibiting the Mas receptor, it enables detailed analysis of endothelial cell signaling, smooth muscle cell proliferation, and extracellular matrix dynamics. The analog's enhanced stability facilitates long-term studies aimed at understanding angiogenesis, vascular inflammation, and the interplay between different components of the vascular wall. Its application continues to drive advances in the field by providing insights into the regulation of vascular health and disease.

1. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

4. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

5. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides